The Omicron variant of the coronavirus does not have a negative effect on cardiovascular health in young adults who have been vaccinated, a small study suggests. Additionally, women should not delay routine mammograms after receiving a COVID-19 mRNA vaccine, experts now say.
U.S. advisory panel to weigh in on COVID boosters for children
Advisory Committees, BNT162b2 (Pfizer and BioNTech), Coronavirus Disease (COVID-19) Pandemic, Coronavirus Vaccines, COVID-19 booster shots, COVID-19 shots, COVID-19 Vaccinations, COVID-19 Vaccines, FDA, Janssen COVID-19 Vaccine (J&J), mRNA-1273/Moderna COVID-19 Vaccine (Moderna), Pandemics, Therapeutics, Vaccinations, Vaccines and Related Biological Products Advisory Committee, Vaxzevria (previously COVID-19 Vaccine AstraZeneca)An advisory panel to the U.S. Centers for Disease Control and Prevention (CDC) is meeting on May 19 to discuss whether to recommend COVID-19 vaccine booster shots for children ages 5 to 11, a group that is just 29% vaccinated so far.
EMA Accepts Filing of Marketing Authorization Application for Valneva’s Inactivated COVID-19 Vaccine Candidate
Committee for Medicinal Products for Human Use (CHMP), COVID-19 Vaccinations, Europe, European Commission, European Medicines Agency, Marketing Authorization Application (MAA), R&D, Vaccine Companies, ValnevaValneva SE confirmed that the European Medicines Agency accepted the filing of a marketing authorization application (MAA) for the specialty vaccine company’s inactivated, whole-virus COVID-19 vaccine candidate, VLA2001.
U.S. FDA authorizes Pfizer’s COVID booster shot for young children
BNT162b2 (Pfizer and BioNTech), Children 5-11 Years, Coronavirus Disease (COVID-19) Pandemic, COVID-19 booster shots, COVID-19 shots, COVID-19 Vaccinations, COVID-19 Vaccines, Emergency Use Authorization (EUA), FDA, Pandemics, Pediatric, Pediatric Vaccines, Pfizer, Therapeutics, VaccinationsThe U.S. Food and Drug Administration on May 17 authorized the use of a booster shot of Pfizer and BioNTech’s COVID-19 vaccine for children aged 5 to 11, making everyone in the United States over the age of 5 eligible for a third shot.
Explainer: How North Korea’s COVID-19 outbreak could ignite a major health crisis
Coronavirus, Coronavirus Diagnostic Tests, Coronavirus Disease (COVID-19) Pandemic, Coronavirus Vaccines, COVAX Facility, COVID-19 Crisis, COVID-19 Deaths, COVID-19 Molecular Diagnostic Tests, COVID-19 self-testing kit, COVID-19 shots, COVID-19 Testing, Covid-19 Testing Guidance, COVID-19 Therapeutic, COVID-19 vaccination rates, COVID-19 Vaccinations, COVID-19 Vaccines, Diagnostic Tests, North Korea, Outbreaks, Pandemics, Politics, South Korea, Vaccinations, Vaccines, World Health OrganizationNorth Korea’s admission that it is battling an “explosive” COVID-19 outbreak raised concerns that the virus could devastate a country with an under-resourced health system, limited testing capabilities, and no vaccine program.
North Korea reports first COVID outbreak, orders lockdown in “gravest emergency”
Coronavirus, COVAX Facility, COVID-19 Infections, COVID-19 Lockdown Measures, COVID-19 vaccination rates, COVID-19 Vaccinations, North Korea, Omicron (B.1.1.529) (South Africa), Outbreaks, Pyongyang, South Korea, World Health OrganizationNorth Korea reported the country’s first COVID-19 outbreak on May 12, calling it the “gravest national emergency” and ordering a national lockdown, with state media saying an Omicron variant had been detected in the capital, Pyongyang.
Janssen terminated a seven-year-old vaccine collaboration with Bavarian Nordic. The two companies partnered in 2015 to develop potential vaccines against the hepatitis B virus and human papillomaviruses.
U.S. health officials on May 6 said they are investigating 109 cases of severe hepatitis of unknown origin in children, including five reported deaths, updating a nationwide alert issued in April for doctors to be on the lookout for such cases of the liver disease.
Obesity may weaken vaccine protection; unvaccinated Omicron patients face risk from variants
AstraZeneca, BNT162b2 (Pfizer and BioNTech), Body Mass Index (BMI), CoronaVac (Sinovac Biotech), COVID-19 immunity, COVID-19 Studies, COVID-19 Vaccinations, COVID-19 Vaccines, Covid-19 Variants, Hospitalized COVID-19 Patients, Immune System, Janssen COVID-19 Vaccine (J&J), Johnson & Johnson, Medical Journals, Messenger RNA (mRNA) Vaccines, mRNA-1273/Moderna COVID-19 Vaccine (Moderna), Nature, Nature Communications, Obesity, Omicron (B.1.1.529) (South Africa), R&D, SARS-CoV-2 virus, Sinovac, South Africa, TurkeySevere obesity may weaken the effectiveness of COVID-19 vaccines in those who have never been infected with the coronavirus, according to a small Turkish study. Additionally, South African researchers have found infection with the Omicron variant of the coronavirus can significantly improve the immune system’s ability to protect against other variants, but only in people who have been vaccinated.
WTO meeting on COVID vaccine rights waiver went ‘very well’ – chair
Coronavirus Disease (COVID-19) Pandemic, Coronavirus Vaccines, COVID-19 Vaccinations, COVID-19 Vaccines, Intellectual Property, Intellectual Property, Intellectual Property Protection, Pandemics, Patent Waiver, Patent Waivers, Therapeutics, Vaccinations, World Trade Organisation (WTO)The first World Trade Organization meeting to discuss a draft agreement to temporarily waive intellectual property rights for COVID-19 vaccines went “very well”, its chair said on May 6.